What's new? Log in Free sign up

Filing search / VYNE Therapeutics Inc. / "Employee"

Search information

VYNE Therapeutics Inc.

Companies

"Employee"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

181 results

Newest first Best match first

VYNE VYNE Therapeutics Inc.

Registration of securities for employees

filed on December 13, 2023). 4.6 Form of Employee Option Grant Notice and Option Agreement under the 2023 Equity Incentive Plan (incorporated

VYNE VYNE Therapeutics Inc.

Definitive proxy

and regulations of Nasdaq and is a “non-employee director” as defined in Rule 16b-3 promulgated under the Exchange Act. Our executive officers submit … number of employees remaining at the Company and the increase in each employee’s responsibilities; (ii) the impact of the loss of any employee, especially

12 Nov 24

4:01pm

VYNE VYNE Therapeutics Inc.

Quarterly report

: Trade payables Accrued expenses Employee related obligations Operating lease liabilities Other current liabilities Total Current Liabilities Long-term … issued under employee stock purchase plan Stock-based compensation Redemption of convertible preferred stock Issuance of common stock in at-the-market

7 Nov 24

4:07pm

VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

of VYN202 of $5.0 million and $1.7 million, respectively. Both trials were initiated in June 2024. In addition, employee-related expenses increased … -current Assets Total Assets Liabilities and Stockholders’ Equity Current Liabilities: Trade payables Accrued expenses Employee related obligations

VYNE VYNE Therapeutics Inc.

Quarterly report

payables Accrued expenses Employee related obligations Operating lease liabilities Other current liabilities Total Current Liabilities Long-term … under employee stock purchase plan Stock-based compensation Redemption of convertible preferred stock Issuance of common stock in at-the-market offering

14 Aug 24

4:01pm

7k8 n0t00wa98d40

VYNE Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Quarterly report

9 May 24

4:01pm

VYNE Reports First Quarter 2024 Financial Results and Provides Business Update

Shelf registration

1 Mar 24

5:16pm

Registration of securities for employees

Registration of securities for employees

fqb6g10um96t7zh

Registration of securities for employees

Registration of securities for employees

1 Mar 24

4:01pm

1 Mar 24

4:01pm

nh20ei0 qe22od6b

1 Mar 24

4:01pm

1 Mar 24

4:01pm

VYNE Reports 2023 Fourth Quarter and Year-End Financial Results and Provides Business Update

x5p5v83hx 94sp6u5qj

VYNE Therapeutics Appoints Christine Borowski, Ph.D., to its Board of Directors

Registration of securities for employees

Prev
1
2
3
4
5
...
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.